Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome
Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency characterized by the contradictory coexistence of impaired T-cell function and exaggerated T-cell-mediated pathology, including autoimmunity and eczema. WAS protein (WASp)-deficient mice are also immunodeficient and can develop autoimmune...
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 124(2007), 1 vom: 15. Juli, Seite 41-8 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , |
Format: | Aufsatz |
Sprache: | English |
Veröffentlicht: |
2007
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Journal Article Research Support, N.I.H., Intramural Forkhead Transcription Factors Interleukin-2 Receptors, Interleukin-2 Wiskott-Aldrich Syndrome Protein |
Zusammenfassung: | Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency characterized by the contradictory coexistence of impaired T-cell function and exaggerated T-cell-mediated pathology, including autoimmunity and eczema. WAS protein (WASp)-deficient mice are also immunodeficient and can develop autoimmune disease. Since defects in regulatory T-cells (Treg) are associated with autoimmunity, we examined the presence and function of these cells in WAS patients and WASp-deficient mice. We found that CD4(+)CD25(+)FOXP3(+) Treg cells can develop in the absence of WASp expression. However, Treg cells both from WASp-deficient mice and from four out of five WAS patients studied showed impaired in vitro suppressor function. In WASp-deficient mice, this defect could be partially rescued by pre-activation with IL-2, suggesting that inadequate cell activation may play a role in WASp-deficient Treg dysfunction. These findings may provide insights into the complex pathophysiology and paradoxical phenotypes of WAS and suggest new therapeutic modalities for autoimmunity in these patients |
---|---|
Beschreibung: | Date Completed 10.08.2007 Date Revised 10.05.2024 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1521-7035 |